Pathomechanisms of ischemia-reperfusion injury as the basis for novel preventive strategies: is it time for the introduction of pleiotropic compounds? (Q36760596)

From Wikidata

Jump to navigation Jump to search

scientific article published on March 2007

Language	Label	Description	Also known as
English	Pathomechanisms of ischemia-reperfusion injury as the basis for novel preventive strategies: is it time for the introduction of pleiotropic compounds?	scientific article published on March 2007

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

1 reference

Europe PubMed Central

Pathomechanisms of ischemia-reperfusion injury as the basis for novel preventive strategies: is it time for the introduction of pleiotropic compounds? (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

reperfusion injury

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Menger MD

1

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

Vollmar B

2

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

language of work or name

0 references

publication date

1 March 2007

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

Transplantation Proceedings

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

39

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

485-488

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

Apoptosis versus oncotic necrosis in hepatic ischemia/reperfusion injury

1 reference

https://api.crossref.org/works/10.1016/J.TRANSPROCEED.2007.01.022

7 January 2021

Cold-induced apoptosis of rat liver cells in University of Wisconsin solution: the central role of chelatable iron

1 reference

https://api.crossref.org/works/10.1016/J.TRANSPROCEED.2007.01.022

7 January 2021

Improvement of rat liver graft quality by pifithrin-alpha-mediated inhibition of hepatocyte necrapoptosis

1 reference

https://api.crossref.org/works/10.1016/J.TRANSPROCEED.2007.01.022

7 January 2021

Role of microcirculation in transplantation

1 reference

https://api.crossref.org/works/10.1016/J.TRANSPROCEED.2007.01.022

7 January 2021

Endothelin-1 is involved in hepatic sinusoidal vasoconstriction after ischemia and reperfusion

1 reference

https://api.crossref.org/works/10.1016/J.TRANSPROCEED.2007.01.022

7 January 2021

Microvascular dysfunction in postischemic skeletal muscle

1 reference

https://api.crossref.org/works/10.1016/J.TRANSPROCEED.2007.01.022

7 January 2021

The microcirculation and inflammation: modulation of leukocyte-endothelial cell adhesion.

1 reference

https://api.crossref.org/works/10.1016/J.TRANSPROCEED.2007.01.022

7 January 2021

Impact of leukocyte-endothelial cell interaction in hepatic ischemia-reperfusion injury

1 reference

https://api.crossref.org/works/10.1016/J.TRANSPROCEED.2007.01.022

7 January 2021

Liver ischemia and reperfusion induces a systemic inflammatory response through Kupffer cell activation

1 reference

https://api.crossref.org/works/10.1016/J.TRANSPROCEED.2007.01.022

7 January 2021

Role of neutrophils in acute inflammatory liver injury

1 reference

https://api.crossref.org/works/10.1016/J.TRANSPROCEED.2007.01.022

7 January 2021

Molecular characterization of rat leukocyte P-selectin glycoprotein ligand-1 and effect of its blockade: protection from ischemia-reperfusion injury in liver transplantation

1 reference

https://api.crossref.org/works/10.1016/J.TRANSPROCEED.2007.01.022

7 January 2021

Leukocytes contribute to hepatic ischemia/reperfusion injury via intercellular adhesion molecule-1-mediated venular adherence

1 reference

https://api.crossref.org/works/10.1016/J.TRANSPROCEED.2007.01.022

7 January 2021

Adhesion molecules as determinants of disease: from molecular biology to surgical research

1 reference

https://api.crossref.org/works/10.1016/J.TRANSPROCEED.2007.01.022

7 January 2021

PECAM-1/IgG attenuates peroxynitrite-mediated extremity reperfusion injury

1 reference

https://api.crossref.org/works/10.1016/J.TRANSPROCEED.2007.01.022

7 January 2021

ESAM supports neutrophil extravasation, activation of Rho, and VEGF-induced vascular permeability

1 reference

https://api.crossref.org/works/10.1016/J.TRANSPROCEED.2007.01.022

7 January 2021

Organ preservation

1 reference

https://api.crossref.org/works/10.1016/J.TRANSPROCEED.2007.01.022

7 January 2021

Direct Anti-Inflammatory Mechanisms Contribute to Attenuation of Experimental Allograft Arteriosclerosis by Statins

1 reference

https://api.crossref.org/works/10.1016/J.TRANSPROCEED.2007.01.022

7 January 2021

Simvastatin inhibits inflammatory properties of Staphylococcus aureus alpha-toxin

1 reference

https://api.crossref.org/works/10.1016/J.TRANSPROCEED.2007.01.022

7 January 2021

Pretreatment with simvastatin reduces myocardial no-reflow by opening mitochondrial K(ATP) channel

1 reference

https://api.crossref.org/works/10.1016/J.TRANSPROCEED.2007.01.022

7 January 2021

Simvastatin exerts both anti-inflammatory and cardioprotective effects in apolipoprotein E-deficient mice.

1 reference

https://api.crossref.org/works/10.1016/J.TRANSPROCEED.2007.01.022

7 January 2021

Discovering erythropoietin's extra-hematopoietic functions: biology and clinical promise

1 reference

https://api.crossref.org/works/10.1016/J.TRANSPROCEED.2007.01.022

7 January 2021

Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling

1 reference

https://api.crossref.org/works/10.1016/J.TRANSPROCEED.2007.01.022

7 January 2021

A nonerythropoietic derivative of erythropoietin protects the myocardium from ischemia-reperfusion injury

1 reference

https://api.crossref.org/works/10.1016/J.TRANSPROCEED.2007.01.022

7 January 2021

Mechanism of the cardioprotection of rhEPO pretreatment on suppressing the inflammatory response in ischemia-reperfusion

1 reference

https://api.crossref.org/works/10.1016/J.TRANSPROCEED.2007.01.022

7 January 2021

Heme oxygenase-1 as a potential therapeutic target for hepatoprotection

1 reference

https://api.crossref.org/works/10.1016/J.TRANSPROCEED.2007.01.022

7 January 2021

Hemoglobin provides protection against lethal endotoxemia in rats: the role of heme oxygenase-1

1 reference

https://api.crossref.org/works/10.1016/J.TRANSPROCEED.2007.01.022

7 January 2021

Induction of heme-oxygenase 1 inhibits endothelial cell activation by endotoxin and oxidant stress

1 reference

https://api.crossref.org/works/10.1016/J.TRANSPROCEED.2007.01.022

7 January 2021

Induction of heme-oxygenase-1 prevents the systemic responses to hemorrhagic shock

1 reference

https://api.crossref.org/works/10.1016/J.TRANSPROCEED.2007.01.022

7 January 2021

Expression of heme oxygenase-1 can determine cardiac xenograft survival

1 reference

https://api.crossref.org/works/10.1016/J.TRANSPROCEED.2007.01.022

7 January 2021

Local heat-shock priming-induced improvement in microvascular perfusion in osteomyocutaneous flaps is mediated by heat-shock protein 32

1 reference

https://api.crossref.org/works/10.1016/J.TRANSPROCEED.2007.01.022

7 January 2021

Reduction of inflammatory response in composite flap transfer by local stress conditioning-induced heat-shock protein 32.

1 reference

https://api.crossref.org/works/10.1016/J.TRANSPROCEED.2007.01.022

7 January 2021

Inhibition of ischemia/reperfusion injury and chronic graft deterioration by a single-donor treatment with cobalt-protoporphyrin for the induction of heme oxygenase-1.

1 reference

https://api.crossref.org/works/10.1016/J.TRANSPROCEED.2007.01.022

7 January 2021

L-Glycine: a novel antiinflammatory, immunomodulatory, and cytoprotective agent

1 reference

https://api.crossref.org/works/10.1016/J.TRANSPROCEED.2007.01.022

7 January 2021

Extended experience with glycine for prevention of reperfusion injury after human liver transplantation

1 reference

https://api.crossref.org/works/10.1016/J.TRANSPROCEED.2007.01.022

7 January 2021

HEGPOL: randomized, placebo controlled, multicenter, double-blind clinical trial to investigate hepatoprotective effects of glycine in the postoperative phase of liver transplantation [ISRCTN69350312].

1 reference

https://api.crossref.org/works/10.1016/J.TRANSPROCEED.2007.01.022

7 January 2021

Identifiers

10.1016/J.TRANSPROCEED.2007.01.022

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36760596&oldid=1548722590"